NCT03657433View on ClinicalTrials.gov

Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

PHASE3CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

August 27, 2021

Study Completion Date

April 1, 2022

Conditions
Iron Deficiency Anemia of Pregnancy
Interventions
DIETARY_SUPPLEMENT

Ferrous sulfate 325mg

Oral tablets supplied for home use

DRUG

Ferumoxytol

Ferumoxytol will be administered in two infusions, one week apart

Trial Locations (1)

85724

University of Arizona, Tucson

Sponsors
All Listed Sponsors
collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

lead

University of Arizona

OTHER